INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 103 filers reported holding INSMED INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,576,000 | -42.0% | 90,000 | -56.1% | 0.02% | -38.2% |
Q4 2016 | $2,715,000 | -8.9% | 205,200 | 0.0% | 0.03% | +6.2% |
Q3 2016 | $2,980,000 | +47.3% | 205,200 | 0.0% | 0.03% | +52.4% |
Q2 2016 | $2,023,000 | -22.2% | 205,200 | 0.0% | 0.02% | +10.5% |
Q1 2016 | $2,600,000 | -13.3% | 205,200 | +24.2% | 0.02% | +5.6% |
Q4 2015 | $2,998,000 | – | 165,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |